中国医科大学学报

中国医科大学学报

中国医科大学学报 ›› 2016, Vol. 45 ›› Issue (5): 426–429.doi: 10.12007/j.issn.0258-4646.2016.05.011

• 论著 • 上一篇    下一篇

宫颈癌术前预置双J管在术后补充放疗前最佳拔管时间的临床研究

张春梅,刘贵鹏,范长友   

  1. 中国医科大学附属盛京医院妇产科,沈阳 110004
  • 收稿日期:2016-01-18 出版日期:2016-05-30 发布日期:2016-05-09
  • 通讯作者: 刘贵鹏 E-mail:liugp@sj?hospital.org
  • 作者简介:张春梅(1986 -),女,医师,硕士.
  • 基金资助:
    辽宁省科技厅优秀人才培育项目(2014021020)

Optimum Timing of Removal of Preoperative Double J Stent before Adjuvant Radiotherapy in Cervical Cancer

ZHANG Chunmei,LIU Guipeng,FAN Changyou   

  1. Department of Obstetrics and Gynecology,Shengjing Hospital,China Medical University,Shenyang 110004,China
  • Received:2016-01-18 Online:2016-05-30 Published:2016-05-09

摘要: 目的 探讨宫颈癌术前预置双 J 管在术后补充放疗前的最佳拔管时间。方法 回顾性分析 2014 年 1 月至 2015 年 3 月因宫颈癌于我院行开腹或腹腔镜下宫颈癌根治术、术前预置双 J 管并于术后补充放疗前拔管的患者 90 例。按照拔出双 J 管的不同时间分为 3 组:术后 2~<4 周拔管组(A 组),共 21 例;术后 4~<5 周拔管组(B 组),共 46 例;术后≥5 周拔管组(C 组),共 23 例。比较各组间置管相关并发症及拔管后并发症的改善情况,以确定拔出双 J 管的最佳时间。结果 B 组总体置管相关并发症发生率(23.91%)显著低于 A 组(47.62%)和 C 组(56.52%),差异有统计学意义(P < 0.05),以膀胱刺激征和置管发热最常见,发生率均为 8.70%。拔管后 A 组肾积水加重率(28.57%)显著高于 B 组(6.52%)和 C 组(4.35%),差异有统计学意义(P < 0.05);其余各组并发症均自行消失或好转。且 3 组比较,肾小球滤过率、血尿素氮及血清肌酐等方面的差异均无统计学意义(P > 0.05)。结论宫颈癌术前预置的双 J 管随着置管时间的延长,其相关并发症发生率显著增加,然而拔管时间过早亦可引起肾积水加重,因此建议最佳拔管时间为术后 4~5 周。

关键词: 宫颈癌, 双J管, 补充放疗, 拔管时间

Abstract: Objective To explore the optimum time of removal of preoperative double J stent before adjuvant radiotherapy in cervical cancer. Methods A total of 90 patients with cervical cancer who underwent radical surgery between January 2014 and March 2015 were retrospectively analyzed. In addition,these recruited patients also underwent preoperative placement of double J stent and had them removed before the adjuvant radiotherapy. The patients were then divided into three groups based on the time of removal of double J stent. Group A(n = 21)had the stent removed 2 to 4 weeks after the surgery;group B(n = 46)had the stent removed 4 to 5 weeks after the surgery;group C(n = 23)had the stent removed greater than or equal to 5 weeks after the surgery. The complications caused by stent placement and their improvement after stent removal were compared among the three groups. Finally,the optimum time of stent removal was determined. ResultsThe overall incidence of complications caused by stent placement in group B(23.91%)was significantly lower(P < 0.05)than that in group A(47.62%)and group C(56.52%). The most frequent among these complications were bladder irritation(8.70%)and fever(8.70%). The incidence of hydronephrosis exacerbation after stent removal in group A(28.57%)was significantly higher(P < 0.05)than that in group B(6.52%)and group C(4.35%). All the other complications were alleviated or disappeared after the removal in all the three groups. There were no significant difference(P > 0.05)among the three groups concerning glomerular filtration rate,serum urea nitrogen,and serum creatinine. Conclusion The incidence of complications caused by preoperative double J stent place- ment increased along with the duration of placement,but the exacerbation of hydronephrosis should be concerned if the stent is removed too early. Therefore,the optimal time of stent removal is 4 to 5 weeks after the surgery.

Key words: cervical cancer, double J stent, adjuvant radiotherapy, time of removal

中图分类号: 

  • R711.74
[1] 蒋建发, 邓新粮, 薛敏. 宫颈印戒细胞癌合并透明细胞癌1例报告并文献复习[J]. 中国医科大学学报, 2018, 47(4): 368-370.
[2] 肖莉,万义增,王宝,李黎. 宫颈上皮内瘤变及鳞癌组织中组蛋白去乙酰化酶1的表达及与HPV16/18感染的关系[J]. 中国医科大学学报, 2015, 44(5): 464-467.
[3] 赵丽雅,庞晓燕,陈青青,孟祥凯,张颐,王化丽. 老年子宫颈高危型HPV感染与子宫颈病变的相关性分析[J]. 中国医科大学学报, 2014, 43(8): 691-693.
[4] 叶郁红,张声,王行富,王密. 宫颈癌相关危险因素分析[J]. 中国医科大学学报, 2014, 43(7): 659-660.
[5] 庞晓奡,张瑶,魏恒,张晶,罗清双,黄成琳,张淑兰. 高迁移率族蛋白1在宫颈癌中的表达及作用[J]. 中国医科大学学报, 2014, 43(12): 1075-1078.
[6] 李朦,刘震,魏力. RUNX3蛋白在宫颈癌中的表达及临床意义[J]. 中国医科大学学报, 2013, 42(9): 812-815.
[7] 张雨芹,李响,王学梅,宛伟娜,李平. 三维能量多普勒对宫颈癌放疗疗效评估的价值[J]. 中国医科大学学报, 2013, 42(9): 836-838.
[8] 穆庆,魏恒,张瑶,罗清双,庞晓奡,张淑兰*. Wnt-11及其受体在宫颈鳞癌中的表达及意义[J]. 中国医科大学学报, 2013, 42(5): 420-424.
[9] 张丹晔,刘娟娟,刘水策,刘冰莹,宫婷婷,林蓓. 妊娠期子宫颈癌22例临床分析[J]. 中国医科大学学报, 2013, 42(2): 175-178.
[10] 张文陆,王言,崔慧霞. 子宫颈癌放疗同步化疗治疗中顺铂用药临床观察[J]. 中国医科大学学报, 2013, 42(12): 1087-1090.
[11] 王宁,张扬,王诗卓,张乔,魏恒,李威,银铎,鲁艳明,戴淑艳,张淑兰. TNF-α基因rs1800629位点多态性与汉族人群宫颈癌发生风险无关[J]. 中国医科大学学报, 2012, 41(8): 730-733.
[12] 王冬冬,王晓黎,林蓓. IDO基因转染对裸鼠体内宫颈癌种植瘤生长的影响 [J]. 中国医科大学学报, 2012, 41(3): 201-204.
[13] 吕昌帅,丁佰娟,刘洪丽,姜侃,张友忠. 阳离子卟啉对宫颈癌细胞株Caski的光动力学杀伤效应[J]. 中国医科大学学报, 2012, 41(11): 981-985.
[14] 王晓黎,王冬冬,赖亚新,林蓓. NK4基因转染对人宫颈癌细胞CaSki生物学特性的影响[J]. 中国医科大学学报, 2012, 41(1): 38-41.
[15] 李智伟, 朱一迪, 温放. 早期宫颈癌盆腔淋巴结微转移免疫组化法检测及临床价值[J]. 中国医科大学学报, 2009, 38(12): 933-.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!

中国医科大学学报版权所有©2018

未经允许,严禁擅自转载本站图文资料

地址:中国 沈阳市沈北新区蒲河路77号 110122

辽ICP备05014850

JOURNAL OF CHINA MEDICAL UNIVERSITY

ADDRESS: NO.77 PUHE ROAD

SHENYANG NORTH NEW AREA, SHENYANG

LIAONING PROVINCE, P.R. CHINA